BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10323198)

  • 1. Structural requirements for cellular uptake of alpha-helical amphipathic peptides.
    Scheller A; Oehlke J; Wiesner B; Dathe M; Krause E; Beyermann M; Melzig M; Bienert M
    J Pept Sci; 1999 Apr; 5(4):185-94. PubMed ID: 10323198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of sidechain hydrophobicity and alpha-helical propensity on the stability of the single-stranded amphipathic alpha-helix.
    Monera OD; Sereda TJ; Zhou NE; Kay CM; Hodges RS
    J Pept Sci; 1995; 1(5):319-29. PubMed ID: 9223011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the cellular uptake of substance P and lysine-rich, KLA-derived model peptides.
    Oehlke J; Lorenz D; Wiesner B; Bienert M
    J Mol Recognit; 2005; 18(1):50-9. PubMed ID: 15386618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphipathic, alpha-helical antimicrobial peptides.
    Tossi A; Sandri L; Giangaspero A
    Biopolymers; 2000; 55(1):4-30. PubMed ID: 10931439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues.
    Song YM; Park Y; Lim SS; Yang ST; Woo ER; Park IS; Lee JS; Kim JI; Hahm KS; Kim Y; Shin SY
    Biochemistry; 2005 Sep; 44(36):12094-106. PubMed ID: 16142907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides.
    Wolf Y; Pritz S; Abes S; Bienert M; Lebleu B; Oehlke J
    Biochemistry; 2006 Dec; 45(50):14944-54. PubMed ID: 17154532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini.
    Lequin O; Ladram A; Chabbert L; Bruston F; Convert O; Vanhoye D; Chassaing G; Nicolas P; Amiche M
    Biochemistry; 2006 Jan; 45(2):468-80. PubMed ID: 16401077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides.
    Scheller A; Wiesner B; Melzig M; Bienert M; Oehlke J
    Eur J Biochem; 2000 Oct; 267(19):6043-50. PubMed ID: 10998065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane association, electrostatic sequestration, and cytotoxicity of Gly-Leu-rich peptide orthologs with differing functions.
    Vanhoye D; Bruston F; El Amri S; Ladram A; Amiche M; Nicolas P
    Biochemistry; 2004 Jul; 43(26):8391-409. PubMed ID: 15222751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of basic amphipathic peptides for cellular delivery of antisense peptide nucleic acids.
    Maier MA; Esau CC; Siwkowski AM; Wancewicz EV; Albertshofer K; Kinberger GA; Kadaba NS; Watanabe T; Manoharan M; Bennett CF; Griffey RH; Swayze EE
    J Med Chem; 2006 Apr; 49(8):2534-42. PubMed ID: 16610796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of a central proline in model amphipathic alpha-helical peptides to self-association, interaction with phospholipids, and antimicrobial mode of action.
    Yang ST; Lee JY; Kim HJ; Eu YJ; Shin SY; Hahm KS; Kim JI
    FEBS J; 2006 Sep; 273(17):4040-54. PubMed ID: 16889633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capillary electrophoresis of amphipathic alpha-helical peptide diastereomers.
    Popa TV; Mant CT; Hodges RS
    Electrophoresis; 2004 Jan; 25(1):94-107. PubMed ID: 14730573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular uptake of Aib-containing amphipathic helix peptide.
    Wada S; Tsuda H; Okada T; Urata H
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5688-91. PubMed ID: 21875799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide.
    Koo YS; Kim JM; Park IY; Yu BJ; Jang SA; Kim KS; Park CB; Cho JH; Kim SC
    Peptides; 2008 Jul; 29(7):1102-8. PubMed ID: 18406495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphipathic peptides and drug delivery.
    Fernández-Carneado J; Kogan MJ; Pujals S; Giralt E
    Biopolymers; 2004; 76(2):196-203. PubMed ID: 15054899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive cellular uptake into endothelial cells of an amphipathic beta-sheet forming peptide.
    Oehlke J; Krause E; Wiesner B; Beyermann M; Bienert M
    FEBS Lett; 1997 Sep; 415(2):196-9. PubMed ID: 9350995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamics of the alpha-helix-coil transition of amphipathic peptides in a membrane environment: implications for the peptide-membrane binding equilibrium.
    Wieprecht T; Apostolov O; Beyermann M; Seelig J
    J Mol Biol; 1999 Dec; 294(3):785-94. PubMed ID: 10610796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
    Lee DL; Hodges RS
    Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of shortening lactoferrin derived peptides against tumour cells, bacteria and normal human cells.
    Yang N; Strøm MB; Mekonnen SM; Svendsen JS; Rekdal O
    J Pept Sci; 2004 Jan; 10(1):37-46. PubMed ID: 14959890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action of linear amphipathic alpha-helical antimicrobial peptides.
    Oren Z; Shai Y
    Biopolymers; 1998; 47(6):451-63. PubMed ID: 10333737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.